MedTrace Logo

Comparison of Two Different Norepinephrine Bolus Doses for Management of Spinal Anesthesia-Induced Maternal Hypotension

NCT05502146 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-01-18

No results posted yet for this study

Summary

In this study the investigators will compare two doses of norepinephrine bolus (6 mcg and 8 mcg) in management of maternal hypotensive episode after spinal block during cesarean delivery.

Conditions

  • Spinal Anesthetic Toxicity
  • Hypotension Drug-Induced
  • Cesarean Section Complications

Interventions

DRUG

Noradrenaline Bitartrate

An intravenous bolus of norepinephrine 6 mcg will be administered for management of maternal hypotension.

DRUG

Bupivacaine Hydrochloride

Subarachnoid block will be performed using Bupivacaine hydrochloride (2.5 mL)

DRUG

Noradrenaline Bitartrate

An intravenous bolus of norepinephrine 8 mcg will be administered for management of maternal hypotension.

DRUG

Bupivacaine Hydrochloride

Subarachnoid block will be performed using Bupivacaine hydrochloride (2.5 mL)

Sponsors & Collaborators

  • Mersin University

    lead OTHER

Principal Investigators

  • Levent Özdemir, Assist Prof · Mersin University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-17
Primary Completion
2022-10-01
Completion
2022-10-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05502146 on ClinicalTrials.gov